Dako AS-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Dako AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013147
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:デンマーク
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Dako A/S (Dako Denmark), a subsidiary of Agilent Technologies Inc is a diagnostic company. The company’s products include diagnostic antibodies, reagents and kits, software related products, instruments and related products, clone products, and synonym products. It also provides immunohistochemistry products, pharmacodiagnostic products, molecular pathology products, special stain products, flow cytometry products, specific proteins, custom made antibodies, labeled probes and detection systems, special stains kits, and ISH ancillaries and accessories, among others. Dako Denmark offers services such as pre treatment solutions, deployment and instrument services, application and technical support, instrument service agreements, safety data sheets, protocol updates, instrument manuals, and application notes for turbidimetry. The company serves hospitals and research laboratories. It operates in Denmark and the US. Dako Denmark is headquartered in Glostrup, Denmark.

Dako AS – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Dako A/S, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Dako A/S, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Dako A/S, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Dako A/S, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Dako A/S, Medical Devices Deals, 2011 to YTD 2017 9
Dako A/S, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Dako A/S, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Dako Enters into Development Agreement with ONO PHARMA for Opdivo 11
Dako Enters Into Co-Development Agreement With Merck 12
ModiQuest Research Extends Agreement With Dako To Generate Monoclonal Antibody 13
Dako Enters Into Co-Development Agreement With Amgen 14
Dako Enters Into Co-Development Agreement With Amgen 15
Dako Enters Into Co-Development Agreement With Bristol-Myers 16
Dako Denmark Enters Into Co-Development Agreement With Epitomics 17
Licensing Agreements 18
Dako Enters into Licensing Agreement with OriGene Technologies 18
Acquisition 19
Agilent Technologies Completes Acquisition Of Dako From EQT For US$2.2 Billion 19
Dako A/S – Key Competitors 21
Dako A/S – Locations And Subsidiaries 22
Head Office 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Dako A/S, Pharmaceuticals & Healthcare, Key Facts 2
Dako A/S, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Dako A/S, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Dako A/S, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Dako A/S, Deals By Therapy Area, 2011 to YTD 2017 8
Dako A/S, Medical Devices Deals, 2011 to YTD 2017 9
Dako A/S, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Dako Enters into Development Agreement with ONO PHARMA for Opdivo 11
Dako Enters Into Co-Development Agreement With Merck 12
ModiQuest Research Extends Agreement With Dako To Generate Monoclonal Antibody 13
Dako Enters Into Co-Development Agreement With Amgen 14
Dako Enters Into Co-Development Agreement With Amgen 15
Dako Enters Into Co-Development Agreement With Bristol-Myers 16
Dako Denmark Enters Into Co-Development Agreement With Epitomics 17
Dako Enters into Licensing Agreement with OriGene Technologies 18
Agilent Technologies Completes Acquisition Of Dako From EQT For US$2.2 Billion 19
Dako A/S, Key Competitors 21

★海外企業調査レポート[Dako AS-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Black Hills Corporation (BKH)-石油・ガス分野:企業M&A・提携分析
    Summary Black Hills Corporation (BHC) is a vertically-integrated energy company which offers electricity and natural gas. The company produces, transmits, and distributes electricity; and sells natural gas on retail and wholesale basis. It generates electricity from natural gas, coal, diesel oil, an …
  • ITT Inc.:企業の戦略・SWOT・財務情報
    ITT Inc. - Strategy, SWOT and Corporate Finance Report Summary ITT Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Stilo International Plc (STL):企業の財務・戦略的SWOT分析
    Summary Stilo International plc (Stilo) operates as a technology company that offers cloud content solutions. The company’s products include developer tools, XML cloud conversion and SME authoring. It offers digital content and publishes information to multiple channels such as print, web, CD-ROM, s …
  • OneMain Holdings Inc:企業の戦略・SWOT・財務分析
    OneMain Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary OneMain Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Parex Resources Inc (PXT):企業の財務・戦略的SWOT分析
    Summary Parex Resources Inc (Parex) is an oil and gas exploration and development company. The company acquires, explores, develops and produces crude oil and natural gas in South America and the Caribbean. It holds interests in onshore blocks in Magdalena Basins and Colombia's Llanos. Its explorati …
  • Bangladesh Power Development Board:電力:M&Aディール及び事業提携情報
    Summary Bangladesh Power Development Board (BPDB) is an integrated electric utility. It generates using gas, furnace, diesel, hydro, coal and solar; and imports power from India. The company operates independent power plants /SIPP, rental power plant and REB using steam turbine, gas turbine, combine …
  • The Better Drinks Co Limited:企業の戦略・SWOT・財務情報
    The Better Drinks Co Limited - Strategy, SWOT and Corporate Finance Report Summary The Better Drinks Co Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Beiersdorf AG (BEI):企業の財務・戦略的SWOT分析
    Beiersdorf AG (BEI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Groupe Bruxelles Lambert SA:企業の戦略・SWOT・財務情報
    Groupe Bruxelles Lambert SA - Strategy, SWOT and Corporate Finance Report Summary Groupe Bruxelles Lambert SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Ibersol S.G.P.S., S.A.
    Ibersol S.G.P.S., S.A. - Strategy, SWOT and Corporate Finance Report Summary Ibersol S.G.P.S., S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Ocular Therapeutix Inc (OCUL):製薬・医療:M&Aディール及び事業提携情報
    Summary Ocular Therapeutix Inc (Ocular), formerly I-Therapeutix Inc is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for diseases using hydrogel platform technology. The company’s products include DEXTENZA, sustained release travoprost and posterior …
  • Swiber Holdings Ltd (AK3)-石油・ガス分野:企業M&A・提携分析
    Summary Swiber Holdings Limited (Swiber) is a provider of integrated offshore construction and support services to the oil and gas industry. The company offers offshore engineering, procurement, installation and construction (EPIC) and marine support services. Its offshore construction services incl …
  • curasan AG (CURK):企業の財務・戦略的SWOT分析
    curasan AG (CURK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Bharat Bijlee Limited (BBL):企業の財務・戦略的SWOT分析
    Bharat Bijlee Limited (BBL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Samba Private Banking:企業の戦略・SWOT・財務情報
    Samba Private Banking - Strategy, SWOT and Corporate Finance Report Summary Samba Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Intrinsic Therapeutics Inc-医療機器分野:企業M&A・提携分析
    Summary Intrinsic Therapeutics Inc (Intrinsic) is a medical device company that develops medical devices for the treatment of lumbar disc herniations. The company offers prosthesis for partial anulus replacement following discectomy surgery; prosthesis for partial anulus replacement; and anular clos …
  • CorMedix Inc (CRMD):企業の財務・戦略的SWOT分析
    Summary CorMedix Inc (CorMedix) is a commercial-stage pharmaceutical company that develops and commercializes therapeutic products for prevention and treatment of cardiac, renal and infectious diseases. The company offers neutrolin, a non-antibiotic anti-infective developed as a preventative solutio …
  • Citizens Electric Corporation:発電所・企業SWOT分析
    Citizens Electric Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Sun Pharma Advanced Research Company Ltd (SPARC):企業の財務・戦略的SWOT分析
    Summary Sun Pharma Advanced Research Company Ltd (SPARC), a subsidiary of Sun Pharmaceutical Industries Ltd, is a bio pharmaceutical clinical research and development service provider. The company develops active pharmaceutical ingredients, formulations and drug delivery technologies for the treatme …
  • Gerdau S.A.:企業の戦略・SWOT・財務情報
    Gerdau S.A. - Strategy, SWOT and Corporate Finance Report Summary Gerdau S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆